Target Price | $5,707.34 |
Price | $4,606.91 |
Potential | 23.89% |
Number of Estimates | 35 |
35 Analysts have issued a price target Booking 2026 . The average Booking target price is $5,707.34. This is 23.89% higher than the current stock price. The highest price target is $6,500.00 41.09% , the lowest is $4,720.00 2.45% . | |
A rating was issued by 41 analysts: 28 Analysts recommend Booking to buy, 13 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Booking stock has an average upside potential 2026 of 23.89% . Most analysts recommend the Booking stock at Purchase. |
34 Analysts have issued a sales forecast Booking 2025 . The average Booking sales estimate is $25.3b . This is 6.71% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $25.9b 9.13% , the lowest is $24.9b 4.78% .
This results in the following potential growth metrics:
2024 | $23.7b | 11.11% |
---|---|---|
2025 | $25.3b | 6.71% |
2026 | $27.5b | 8.63% |
2027 | $30.2b | 9.66% |
2028 | $32.4b | 7.43% |
2029 | $34.7b | 7.03% |
34 Analysts have issued an Booking EBITDA forecast 2025. The average Booking EBITDA estimate is $9.1b . This is 9.58% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $9.4b 13.20% , the lowest is $8.9b 7.14% .
This results in the following potential growth metrics and future EBITDA Margins:
2024 | $8.3b | 28.21% |
---|---|---|
2025 | $9.1b | 9.07% |
2026 | $10.2b | 12.25% |
2027 | $11.6b | 13.55% |
2028 | $12.8b | 10.18% |
2029 | $14.2b | 11.30% |
2024 | 35.13% | 15.39% |
---|---|---|
2025 | 35.91% | 2.21% |
2026 | 37.10% | 3.31% |
2027 | 38.42% | 3.56% |
2028 | 39.40% | 2.55% |
2029 | 40.97% | 3.98% |
29 Booking Analysts have issued a net profit forecast 2025. The average Booking net profit estimate is $6.7b . This is 17.22% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $7.0b 23.01% , the lowest is $5.9b 3.62% .
This results in the following potential growth metrics and future Net Margins:
2024 | $5.7b | 47.07% |
---|---|---|
2025 | $6.7b | 17.45% |
2026 | $7.8b | 17.31% |
2027 | $9.3b | 19.04% |
2028 | $10.8b | 15.28% |
2029 | $12.4b | 15.50% |
2024 | 23.97% | 32.37% |
---|---|---|
2025 | 26.38% | 10.06% |
2026 | 28.49% | 8.00% |
2027 | 30.92% | 8.53% |
2028 | 33.18% | 7.31% |
2029 | 35.81% | 7.93% |
29 Analysts have issued a Booking forecast for earnings per share. The average Booking EPS is $202.81 . This is 17.22% higher than earnings per share in the financial year 2024. The highest EPS forecast is $212.84 23.01% , the lowest is $179.28 3.62% .
This results in the following potential growth metrics and future valuations:
2024 | $172.68 | 47.07% |
---|---|---|
2025 | $202.81 | 17.45% |
2026 | $237.93 | 17.32% |
2027 | $283.22 | 19.04% |
2028 | $326.50 | 15.28% |
2029 | $377.10 | 15.50% |
Current | 26.63 | 13.40% |
---|---|---|
2025 | 22.72 | 14.68% |
2026 | 19.36 | 14.79% |
2027 | 16.27 | 15.96% |
2028 | 14.11 | 13.28% |
2029 | 12.22 | 13.39% |
Based on analysts' sales estimates for 2025, the Booking stock is valued at an EV/Sales of 6.01 and an P/S ratio of 5.97 .
This results in the following potential growth metrics and future valuations:
Current | 6.41 | 8.46% |
---|---|---|
2025 | 6.01 | 6.24% |
2026 | 5.53 | 7.95% |
2027 | 5.04 | 8.81% |
2028 | 4.70 | 6.92% |
2029 | 4.39 | 6.57% |
Current | 6.37 | 9.75% |
---|---|---|
2025 | 5.97 | 6.29% |
2026 | 5.49 | 7.95% |
2027 | 5.01 | 8.81% |
2028 | 4.66 | 6.92% |
2029 | 4.36 | 6.57% |
Analyst | Rating | Action | Date |
---|---|---|---|
Citizens Capital Markets |
Market Outperform
➜
Market Outperform
|
Unchanged | Feb 24 2025 |
Benchmark |
Buy
➜
Buy
|
Unchanged | Feb 21 2025 |
Cantor Fitzgerald |
Neutral
➜
Neutral
|
Unchanged | Feb 21 2025 |
Wells Fargo |
Equal-Weight
➜
Equal-Weight
|
Unchanged | Feb 21 2025 |
B. Riley Securities |
Buy
➜
Buy
|
Unchanged | Feb 21 2025 |
Citigroup |
Buy
➜
Buy
|
Unchanged | Feb 21 2025 |
Barclays |
Overweight
➜
Overweight
|
Unchanged | Feb 21 2025 |
Analyst Rating | Date |
---|---|
Unchanged
Citizens Capital Markets:
Market Outperform
➜
Market Outperform
|
Feb 24 2025 |
Unchanged
Benchmark:
Buy
➜
Buy
|
Feb 21 2025 |
Unchanged
Cantor Fitzgerald:
Neutral
➜
Neutral
|
Feb 21 2025 |
Unchanged
Wells Fargo:
Equal-Weight
➜
Equal-Weight
|
Feb 21 2025 |
Unchanged
B. Riley Securities:
Buy
➜
Buy
|
Feb 21 2025 |
Unchanged
Citigroup:
Buy
➜
Buy
|
Feb 21 2025 |
Unchanged
Barclays:
Overweight
➜
Overweight
|
Feb 21 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.